Evogene Ltd. (EVGN) stock
EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
$0.36−0.03 (-8.70%)
Close on Nov 12, 2026Market cap $3.15MP/E 0.3Yield –
Evogene EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was $1.08. The highest annual figure on record is $1.08 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.08 | – |
| FY2024 | Dec 31, 2024 | -$2.90 | – |
| FY2023 | Dec 31, 2023 | -$5.20 | – |
| FY2022 | Dec 31, 2022 | -$6.44 | – |
| FY2021 | Dec 31, 2021 | -$6.90 | – |
| FY2020 | Dec 31, 2020 | -$8.30 | – |
| FY2019 | Dec 31, 2019 | -$7.00 | – |
| FY2018 | Dec 31, 2018 | -$8.10 | – |
| FY2017 | Dec 31, 2017 | -$8.10 | – |
| FY2016 | Dec 31, 2016 | -$7.70 | – |
| FY2015 | Dec 31, 2015 | -$6.80 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?